首页> 美国卫生研究院文献>Radiology and Oncology >Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy

【2h】

Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy

机译：一线放化疗后进展期生存对有限期疾病小细胞肺癌患者总生存的临床影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe effects of first-line chemoradiotherapy on overall survival (OS) may be confounded by subsequent lines of therapy in patients with limited-stage disease small cell lung cancer (LD-SCLC). Therefore, we aimed to determine the relationships between progression-free survival (PFS), post-progression survival (PPS) and OS after first-line chemoradiotherapy in LD-SCLC patients.

机译：背景一线放化疗对总生存期（OS）的影响可能与随后在有限期疾病小细胞肺癌（LD-SCLC）患者中的治疗方案混淆。因此，我们旨在确定LD-SCLC患者一线放化疗后无进展生存期（PFS），进展后生存期（PPS）与OS之间的关系。

著录项

期刊名称 Radiology and Oncology
作者
Norimitsu Kasahara; Hisao Imai; Kyoichi Kaira; Keita Mori; Kazushige Wakuda; Akira Ono; Tetsuhiko Taira; Hirotsugu Kenmotsu; Hideyuki Harada; Tateaki Naito; Haruyasu Murakami; Masahiro Endo; Takashi Nakajima; Masanobu Yamada; Toshiaki Takahashi;
展开▼
作者单位

展开▼
年(卷),期 2015(49),4
年度 2015
页码 409–415
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
chemoradiotherapy limited-stage disease small cell lung cancer overall survival post-progression survival progression-free survival;

机译：化学放疗;有限期疾病小细胞肺癌;总生存期;进展后生存期;无进展生存期;

相似文献

外文文献
中文文献
专利

1. Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy [J] . Norimitsu Kasahara, Hisao Imai, Kyoichi Kaira, Radiology and Oncology . 2015,第4期

机译：一线放化疗后进展期生存对有限期疾病小细胞肺癌患者总生存的临床影响
2. Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors [J] . Imai Hisao, Yamada Yutaka, Sugiyama Tomohide, Chemotherapy: International Journal of Experimental and Clinical Chemotherapy . 2018,第3期

机译：患有一线EGFR酪氨酸激酶抑制剂治疗的患有敏感EGFR突变的老年非小细胞肺癌患者整体生存的临床影响
3. The Clinical Impact of the Post-progression Survival on the Overall Survival in Elderly Patients or Those with a Poor Performance Status and Extensive-disease Small-cell Lung Cancer [J] . 肺癌 . 2020,第1期

机译：进展后生存对老年患者整体生存的临床影响或性能地位差和广泛疾病小细胞肺癌
4. The impact of the type of resection on survival in patients with N1 non-small-cell lung cancers [C] . Umit Aydogmus, Levent Cansever, Yasar Sonmezoglu, 21st international conference on screening for lung cancer . 2009

机译：切除类型对N1非小细胞肺癌患者生存的影响
5. An investigation of the determinates of survival in patients with inoperable non-small cell lung cancer: The role of the systemic inflammatory response [D] . Forrest, Lynn M. 2004

机译：不可手术的非小细胞肺癌患者生存决定因素的研究：全身炎症反应的作用
6. The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy [O] . Ahmet Kucuk, Emine Elif Ozkan, Sukran Eskici Oztep, 2020

机译：全身炎症反应指数对经疗法疗法治疗有限阶段小细胞肺癌患者存活结果的影响
7. Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy [O] . Kasahara Norimitsu, Imai Hisao, Kaira Kyoichi, 2015

机译：一线放化疗后有限期疾病小细胞肺癌患者的进展后生存期对总生存率的临床影响

Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy

摘要

著录项

相似文献

相关主题

期刊订阅